SJ Lee

Company: Orum Therapeutics

Job title: Chief Executive Officer

Seminars:

Combining The Power of Protein Degraders With The Precision of Antibodies for Synergistic Potential Using Degrader-Antibody Conjugates (DACs) 8:30 am

Delving into the mechanism and design of an antibody degrader conjugate, considering aspects like linker design for stability and efficient PROTAC release Evaluating safety, pharmacokinetic, pharmacodynamic and anti-tumor activity data Discussing the rationale for the chosen format and value proposition over traditional approachesRead more

day: Scientific Program Day Two AM